firming moisturizing facial cream -...

1
Firming Moisturizing Facial Cream 13316-69 Europe: Sempach-Station, Switzerland, T: +41 (0)41-469-69-66, F: +41 (0)41-469-69-06, e: [email protected] Americas: Bridgewater, New Jersey, U.S.A., T: 888 331-6212, F: 908-707-3664, e: [email protected] South America: Itupeva, SP, Brazil, T: 55-11-4591-8800, F: 55-11-4591-8804, e: [email protected] A Asia/Pacific: Shanghai, P.R. China, Tel: +86-21-5774-5700, Fax: +86-21- 6774-2936, e-mail: [email protected] www.akzonobel.com/PersonalCare AkzoNobel Surface Chemistry Global Personal Care Page 1 of 1 Created Feb 2004 Modified Mar. 1, 2011 Description The FLEXAN ® II film forming polymer delivers skin tightening properties to this facial cream. The HYDROVANCE ® moisturizing agent delivers moisturization efficacy comparable to the leading benchmark while offering non-tacky, non-greasy aesthetic in skin care products. Formula Trade Name INCI Name % w/w Supplier Phase A ESTOL 1462 Glyceryl Stearate SE 7.00% Croda Crystal O Castor Oil 6.00% Cas Chem Emersol 132 Stearic Acid T.P. 3.00% Cognis PRISORINE 2040 Glyceryl Monoisostearate 2.00% Croda HYDROVANCE moisturizing agent Hydroxyethyl Urea 4.00% AkzoNobel Global Personal Care Citroflex 2 Triethyl Citrate 0.10% Morflex, Inc. Fancol CB Cocoa Butter 1.00% Fanning Lipovol WGO Wheat Germ Oil 1.00% Lipo Propylparaben Propylparaben 0.10% Phase B Deionized Water Water (Aqua) q.s. FLEXAN II polymer Sodium Polystyrene Sulfonate 1.67% AkzoNobel Global Personal Care Carbopol 940 (2% Aq. Soln.) Carbomer 10.00% Lubrizol Triethanolamine (99%) Triethanolamine 1.00% Methylparaben Methylparaben 0.15% Phase C Germall II Diazolidinyl Urea 0.15% Sutton Labs Total: 100.00% Procedure Combine Phase B, sift FLEXAN II polymer slowly and mix for 5 minute, heat to 80ºC. Combine Phase A, heat to 80ºC. Add Phase A to Phase B at 80ºC mix for 15 minutes. Cool to 40ºC, add Phase C. Mix thoroughly. Cool to room temperature and package. Properties pH: 6.5 -7.5 Viscosity: 12,800 – 19,200 cps (Brookfield Helipath, Spindle C, 10rpm) All information concerning our products and/or all suggestions for handling and use contained herein (including formulation and toxicity information) are offered in good faith and are believed to be reliable. However Akzo Nobel Surface Chemistry makes no warranty express or implied (i) as to the accuracy or sufficiency of such information and/or suggestions, (ii) as to any product’s merchantability or fitness for a particular use or (iii) that any suggested use (including use in any formulation) will not infringe any patent. Nothing contained herein shall be construed as granting or extending any license under any patent. The user must determine for itself by preliminary tests or otherwise the suitability of any product and of any information contained herein (including but not limited to formulation and toxicity information) for the user’s purpose. The safety of any formulations described herein has not been established. The suitability and safety of a formulation should be confirmed in all respects by the user prior to use. The information contained herein supersedes all previously issued bulletins on the subject matter covered.

Upload: vonga

Post on 30-Jul-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Firming Moisturizing Facial Cream - AkzoNobelsc.akzonobel.com/formulations/AkzoNobel_formulation_1331669.pdf · Title: Firming Moisturizing Facial Cream Author: AkzoNobel Subject:

Firming Moisturizing Facial Cream 13316-69

Europe: Sempach-Station, Switzerland, T: +41 (0)41-469-69-66, F: +41 (0)41-469-69-06, e: [email protected] Americas: Bridgewater, New Jersey, U.S.A., T: 888 331-6212, F: 908-707-3664, e: [email protected] South America: Itupeva, SP, Brazil, T: 55-11-4591-8800, F: 55-11-4591-8804, e: [email protected] A Asia/Pacific: Shanghai, P.R. China, Tel: +86-21-5774-5700, Fax: +86-21- 6774-2936, e-mail: [email protected] www.akzonobel.com/PersonalCare

AkzoNobel Surface Chemistry Global Personal Care

Page 1 of 1 Created Feb 2004 Modified Mar. 1, 2011

Description The FLEXAN® II film forming polymer delivers skin tightening properties to this facial cream. The HYDROVANCE® moisturizing agent delivers moisturization efficacy comparable to the leading benchmark while offering non-tacky, non-greasy aesthetic in skin care products.

Formula Trade Name INCI Name % w/w Supplier Phase A ESTOL 1462 Glyceryl Stearate SE 7.00% Croda Crystal O Castor Oil 6.00% Cas Chem Emersol 132 Stearic Acid T.P. 3.00% Cognis PRISORINE 2040 Glyceryl Monoisostearate 2.00% Croda HYDROVANCE moisturizing agent

Hydroxyethyl Urea 4.00% AkzoNobel Global Personal Care

Citroflex 2 Triethyl Citrate 0.10% Morflex, Inc. Fancol CB Cocoa Butter 1.00% Fanning Lipovol WGO Wheat Germ Oil 1.00% Lipo Propylparaben Propylparaben 0.10% Phase B Deionized Water Water (Aqua) q.s. FLEXAN II polymer Sodium Polystyrene Sulfonate 1.67% AkzoNobel Global

Personal CareCarbopol 940 (2% Aq. Soln.)

Carbomer 10.00% Lubrizol

Triethanolamine (99%) Triethanolamine 1.00% Methylparaben Methylparaben 0.15% Phase C Germall II Diazolidinyl Urea 0.15% Sutton Labs Total: 100.00% Procedure Combine Phase B, sift FLEXAN II polymer slowly and mix for 5 minute, heat to 80ºC. Combine Phase A, heat to 80ºC. Add Phase A to Phase B at 80ºC mix for 15 minutes. Cool to 40ºC, add Phase C. Mix thoroughly. Cool to room temperature and package.

Properties pH: 6.5 -7.5 Viscosity: 12,800 – 19,200 cps (Brookfield Helipath, Spindle C, 10rpm)

All information concerning our products and/or all suggestions for handling and use contained herein (including formulation and toxicity information) are offered in good

faith and are believed to be reliable. However Akzo Nobel Surface Chemistry makes no warranty express or implied (i) as to the accuracy or sufficiency of such information and/or suggestions, (ii) as to any product’s merchantability or fitness for a particular use or (iii) that any suggested use (including use in any formulation) will not infringe any patent. Nothing contained herein shall be construed as granting or extending any license under any patent. The user must determine for itself by preliminary tests or otherwise the suitability of any product and of any information contained herein (including but not limited to formulation and toxicity information) for the user’s purpose. The safety of any formulations described herein has not been established. The suitability and safety of a formulation should be confirmed in all respects by the user prior to use. The information contained herein supersedes all previously issued bulletins on the subject matter covered.